Last reviewed · How we verify
OZODROP
OZODROP is an ozone-based ophthalmic solution that delivers therapeutic ozone to the ocular surface.
OZODROP is an ozone-based ophthalmic solution that delivers therapeutic ozone to the ocular surface. Used for Dry eye disease, Corneal abrasion and epithelial defects, Ocular surface disease.
At a glance
| Generic name | OZODROP |
|---|---|
| Also known as | liposomal ozone-based solution |
| Sponsor | University of Molise |
| Drug class | Ozone therapy / Ophthalmic solution |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | FDA-approved |
Mechanism of action
Ozone acts as an antimicrobial and anti-inflammatory agent when applied topically to the eye. It is believed to enhance oxygen delivery to ocular tissues and promote healing of the corneal and conjunctival epithelium through oxidative mechanisms.
Approved indications
- Dry eye disease
- Corneal abrasion and epithelial defects
- Ocular surface disease
Common side effects
- Ocular irritation
- Transient discomfort
- Conjunctival hyperemia
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |